Dr. Andrea D. Jewell
Claim this profileUniversity of Kansas Cancer Center
Expert in Ovarian Cancer
Studies Fallopian Tube Cancer
18 reported clinical trials
40 drugs studied
About Andrea D. Jewell
Education:
- Earned an MD (Doctor of Medicine) from an unspecified institution.
Experience:
- Serves as Assistant Director, Administration and Education at the University of Kansas Cancer Center.
- Holds the Distinguished Kansas Masonic Professorship in Cancer Research.
Area of expertise
1Ovarian Cancer
Global LeaderStage IV
Stage III
Stage II
2Fallopian Tube Cancer
Stage IV
Stage III
Stage II
Affiliated Hospitals
Clinical Trials Andrea D. Jewell is currently running
Mirvetuximab + Bevacizumab
for Ovarian Cancer
GLORIOSA is a Phase 3 multicenter, open label study designed to evaluate the safety and efficacy of mirvetuximab Soravtansine + Bevacizumab as maintenance therapy in participants with platinum-sensitive ovarian, primary peritoneal or fallopian tube cancers with high folate receptor-alpha (FRα) expression.
Recruiting2 awards Phase 3
Weight Loss Management
for Endometrial Cancer
This study is being done to understand how oncologists can engage a multidisciplinary team to help endometrial cancer survivors with obesity to engage in a weight management program and potentially start a weight loss medication. Obesity often impacts the future health and longevity of early-stage endometrial cancer survivors more than their cancer diagnosis. Patients will be referred to the KUMC OB/Gyn weight management clinic to discuss weight management options. * If patients decide to use medications for weight loss, then the study will collect data from their chart that is recorded as part of routine monitoring for patients on weight loss medications. * If patients decide not to use any medications, the study will monitor physical exam and lab data collected as part of their routine medical care. The study will also try to understand reasons why patients did or did not start using a weight loss medication.
Recruiting1 award N/A7 criteria
More about Andrea D. Jewell
Clinical Trial Related5 years of experience running clinical trials · Led 18 trials as a Principal Investigator · 6 Active Clinical TrialsTreatments Andrea D. Jewell has experience with
- Bevacizumab
- Paclitaxel
- Letrozole
- Atezolizumab
- Cisplatin
- Topotecan
Breakdown of trials Andrea D. Jewell has run
Ovarian Cancer
Fallopian Tube Cancer
Peritoneal Serous Adenocarcinoma
Endometrial Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Andrea D. Jewell specialize in?
Andrea D. Jewell focuses on Ovarian Cancer and Fallopian Tube Cancer. In particular, much of their work with Ovarian Cancer has involved Stage IV patients, or patients who are Stage III.
Is Andrea D. Jewell currently recruiting for clinical trials?
Yes, Andrea D. Jewell is currently recruiting for 6 clinical trials in Westwood Kansas. If you're interested in participating, you should apply.
Are there any treatments that Andrea D. Jewell has studied deeply?
Yes, Andrea D. Jewell has studied treatments such as Bevacizumab, Paclitaxel, Letrozole.
What is the best way to schedule an appointment with Andrea D. Jewell?
Apply for one of the trials that Andrea D. Jewell is conducting.
What is the office address of Andrea D. Jewell?
The office of Andrea D. Jewell is located at: University of Kansas Cancer Center, Westwood, Kansas 66205 United States. This is the address for their practice at the University of Kansas Cancer Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.